切换至 "中华医学电子期刊资源库"

中华结直肠疾病电子杂志 ›› 2015, Vol. 04 ›› Issue (01) : 5 -7. doi: 10.3877/cma.j.issn.2095-3224.2015.01.02

所属专题: 文献

专家论坛

结直肠癌TNM分期的现状及发展方向
王振宁1()   
  1. 1. 110001 沈阳,中国医科大学附属第一医院肿瘤外科
  • 收稿日期:2014-12-05 出版日期:2015-02-25
  • 通信作者: 王振宁

The present issues and the trend of the TNM staging system

Zhen-ning WANG1,()   

  1. 1. Department of Oncology, First Affiliated Hospital of China Medical University, Shenyang 110001, China
  • Received:2014-12-05 Published:2015-02-25
  • Corresponding author: Zhen-ning WANG
  • About author:
    Corresponding author: WANG Zhen-ning, Email: .
引用本文:

王振宁. 结直肠癌TNM分期的现状及发展方向[J]. 中华结直肠疾病电子杂志, 2015, 04(01): 5-7.

Zhen-ning WANG. The present issues and the trend of the TNM staging system[J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2015, 04(01): 5-7.

随着对于结直肠癌研究的逐步深入,每一版的TNM分期都在不停的作出调整。笔者主要结合近年的研究成果对于第七版TNM分期中存在的一些问题进行探讨,并且对第八版TNM分期制定中可能涉及的一些方面进行了展望。

As the study on the colorectal cancer develops, the TNM staging system has been adjusted in every edition.The author discussed several issues in the 7th edition and made some prospects on the coming 8th TNM classification edition on the the hotspots of research fields in recent years.

[1]
American Joint Committee on Cancer,Edge SB.AJCC cancer staging manual,7th edn.New York:Springer,2010.
[2]
Sobin LH, Wittekind C,UICC.TNM classification of malignant tumours,7th ed.Oxford:Wiley-Blackwell,2009.
[3]
Gao P, Song YX, Wang ZN,et al.Is the prediction of prognosis not improved by the seventh edition of the TNM classification for colorectal cancer? Analysis of the surveillance,epidemiology,and end results(SEER)database.BMC Cancer,2013,13:123.
[4]
Ueno H, Mochizuki H, Akagi Y,et al.Optimal colorectal cancer staging criteria in TNM classification.J Clin Oncol,2012,30(13):1519-1526.
[5]
Mori T.A Comparison of the new(Planned)TNM classification and Japanese general rule for staging colorectal cancer.Cancer Investigation,2010,28(4):387-392.
[6]
Nagtegaal ID, Quirke P, Schmoll H-J.Has the new TNM classification for colorectal cancer improved care? Nature Reviews Clinical Oncology,2012,9(2):119-123.
[7]
Nagtegaal ID, Tot T, Jayne DG,et al.Lymph nodes,tumor deposits,and TNM:Are we getting better? Journal of Clinical Oncology,2011,29(18):2487-2492.
[8]
Nitsche U, Maak M, Schuster T,et al.Prediction of prognosis is not improved by the seventh and latest edition of the TNM classification for colorectal cancer in a single-center collective.Annals of Surgery,2011,254(5):793-801.
[9]
Tong LL, Gao P, Wang ZN,et al.Is the seventh edition of the UICC/AJCC TNM staging system reasonable for patients with tumor deposits in colorectal cancer? Ann Surg,2012,255(2):208-213.
[10]
Song YX, Gao P, Wang ZN,et al.Can the tumor deposits be counted as metastatic lymph nodes in the UICC TNM staging system for colorectal cancer? PLoS One,2012,7(3):e34087.
[11]
Qiu HB, Chen G, Keshari RP,et al.The extramural metastasis might be categorized in lymph node staging for colorectal cancer.BMC Cancer,2011,11(1):414.
[12]
Le Voyer TE, Sigurdson ER, Hanlon AL,et al.Colon cancer survival is associated with increasing number of lymph nodes analyzed:a secondary survey of intergroup trial INT-0089.J Clin Oncol,2003,21(15):2912-2919.
[13]
Hashiguchi Y, Hase K, Ueno H,et al.Prognostic significance of the number of lymph nodes examined in colon cancer surgery:clinical application beyond simple measurement.Ann Surg,2010,251(5):872-881.
[14]
Berger AC, Sigurdson ER, LeVoyer T,et al.Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes.J Clin Oncol,2005,23(34):8706-8712.
[15]
Rosenberg R, Engel J, Bruns C,et al.The prognostic value of lymph node ratio in a population-based collective of colorectal cancer patients.Annals of Surgery,2010,251(6):1070-1078.
[16]
Tong L-l, Gao P, Wang Z-n,et al.Can lymph node ratio take the place of pN categories in the UICC/AJCC TNM classification system for colorectal cancer?Annals of Surgical Oncology,2011,18(9):2453-2460.
[17]
Derwinger K, Carlsson G,Gustavsson B:A study of lymph node ratio as a prognostic marker in colon cancer.European Journal of Surgical Oncology(EJSO)2008,34(7):771-775.
[18]
Frédérique P, Stéphane B, Catherine J,et al.The ratio of metastatic to examined lymph nodes is a powerful iIndependent prognostic factor in rectal cancer.Annals of Surgery,2008,248(6):1067-1073.
[19]
O'Connell MJ, Lavery I, Yothers G,et al.Relationship between tumor gene expression and recurrence in four independent studies of patients with stage II/III colon cancer treated with surgery alone or surgery plus adjuvant fluorouracil plus leucovorin.J Clin Oncol,2010,28(25):3937-3944.
[20]
Yothers G, O'Connell MJ, Lee M,et al.Validation of the 12-gene colon cancer recurrence score in NSABP C-07 as a predictor of recurrence in patients with stage II and III colon cancer treated with fluorouracil and leucovorin(FU/LV)and FU/LV plus oxaliplatin.J Clin Oncol,2013,31(36):4512-4519.
[21]
Reimers MS, Kuppen PJ, Lee M,et al.Validation of the 12-gene colon cancer recurrence score as a predictor of recurrence risk in stage II and III rectal cancer patients.J Natl Cancer Inst,2014,106(11).
[22]
Liang JW, Gao P, Wang ZN,et al.The integration of macroscopic tumor invasion of adjacent organs into TNM staging system for colorectal cancer.PLoS One,2012,7(12):e52269.
[23]
Gao P, Song YX, Wang ZN,et al.Integrated ratio of metastatic to examined lymph nodes and number of metastatic lymph nodes into the AJCC staging system for colon cancer.PLoS One,2012,7(4):e35021.
[1] 康夏, 田浩, 钱进, 高源, 缪洪明, 齐晓伟. 骨织素抑制破骨细胞分化改善肿瘤骨转移中骨溶解的机制研究[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 329-339.
[2] 代莉, 邓恢伟, 郭华静, 黄芙蓉. 术中持续输注艾司氯胺酮对腹腔镜结直肠癌手术患者术后睡眠质量的影响[J]. 中华普通外科学文献(电子版), 2023, 17(06): 408-412.
[3] 王得晨, 杨康, 杨自杰, 归明彬, 屈莲平, 张小凤, 高峰. 结直肠癌微卫星稳定状态和程序性死亡、吲哚胺2,3-双加氧酶关系的研究进展[J]. 中华普通外科学文献(电子版), 2023, 17(06): 462-465.
[4] 唐旭, 韩冰, 刘威, 陈茹星. 结直肠癌根治术后隐匿性肝转移危险因素分析及预测模型构建[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 16-20.
[5] 张生军, 赵阿静, 李守博, 郝祥宏, 刘敏丽. 高糖通过HGF/c-met通路促进结直肠癌侵袭和迁移的实验研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 21-24.
[6] 李婷, 张琳. 血清脂肪酸代谢物及维生素D水平与结直肠癌发生的关系研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 661-665.
[7] 关旭, 王锡山. 基于外科与免疫视角思考结直肠癌区域淋巴结处理的功与过[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 448-452.
[8] 顾睿祈, 方洪生, 蔡国响. 循环肿瘤DNA检测在结直肠癌诊治中的应用与进展[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 453-459.
[9] 倪文凯, 齐翀, 许小丹, 周燮程, 殷庆章, 蔡元坤. 结直肠癌患者术后发生延迟性肠麻痹的影响因素分析[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 484-489.
[10] 范小彧, 孙司正, 鄂一民, 喻春钊. 梗阻性左半结肠癌不同手术治疗方案的选择应用[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 500-504.
[11] 黄怡诚, 陆晨, 孙司正, 喻春钊. 肝特异性转录因子FOXA2在人结直肠癌肝转移阶梯模型中的表达变化及其意义[J]. 中华结直肠疾病电子杂志, 2023, 12(05): 396-403.
[12] 刘祺, 张凯, 李建男, 刘铜军. 结直肠癌肝转移生物治疗的现状及进展[J]. 中华结直肠疾病电子杂志, 2023, 12(05): 415-419.
[13] 吴寅, 陈智琴, 高勇, 权明. Her-2阳性结直肠癌的诊治进展[J]. 中华结直肠疾病电子杂志, 2023, 12(05): 420-425.
[14] 范博洋, 王宁, 张骞, 王贵玉. 结直肠癌转移调控的环状RNA分子机制研究进展[J]. 中华结直肠疾病电子杂志, 2023, 12(05): 426-430.
[15] 钟广俊, 刘春华, 朱万森, 徐晓雷, 王兆军. MRI联合不同扫描序列在胃癌术前分期诊断及化疗效果和预后的评估[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 378-382.
阅读次数
全文


摘要